Associate Professor, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Van Yuzuncu Yil University, Van, Turkey.
Assistant Professor, Department of Oral and Maxillofacial Surgery, Van Yuzuncu Yil University, Faculty of Dentistry, Van, Turkey.
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(4S):101501. doi: 10.1016/j.jormas.2023.101501. Epub 2023 May 11.
This study aimed to evaluate the efficacy of a single-dose topical rifamycin application on postoperative complications after impacted lower third molar surgery.
This prospective, controlled clinical study consisted of individuals with bilaterally impacted lower third molars that would be extracted for orthodontic reasons. The extraction sockets were irrigated with 3 ml/250 mg of rifamycin solution in Group 1, while in Group 2 (control group) the extraction sockets were irrigated with 20 ml of physiological saline. Pain intensity was measured daily for 7 days by using visual analog scale. Trismus and edema were evaluated preoperatively and on the postoperative days 2 and 7 by calculating the proportional changes in maximum mouth opening and mean distance between reference points of the face, respectively. Paired samples t-test, Wilcoxon signed rank test and Chi-square test were used to analyze the study variables.
35 patients (19 female, 16 male) were included in the study. The mean age of all participants was 22.19±4.98. Alveolitis was observed in 8 patients, (6 in the control group, 2 in the rifamycin group). There was no statistically significant difference between groups in terms of trismus and swelling measurements on the 2nd and 7th postoperative days (p>0.05). VAS scores were significantly low in rifamycin group on postoperative days 1 and 4 (p<0.05).
Within the limits of the present study, topical rifamycin application reduced the incidence of alveolitis, prevented infection, and provided analgesic effect after surgical removal of impacted third molars.
本研究旨在评估局部应用利福霉素单次剂量对下颌阻生第三磨牙术后并发症的疗效。
本前瞻性、对照临床研究纳入了因正畸原因需拔除双侧下颌阻生第三磨牙的个体。在第 1 组(利福霉素组)中,用 3 毫升/250 毫克利福霉素溶液冲洗拔牙窝,在第 2 组(对照组)中,用 20 毫升生理盐水冲洗拔牙窝。术后第 1 天至第 7 天,采用视觉模拟评分法(VAS)每天测量疼痛强度。在术前、术后第 2 天和第 7 天,通过计算最大张口度和面部参考点之间的平均距离的比例变化来评估张口受限和肿胀。采用配对样本 t 检验、Wilcoxon 符号秩检验和卡方检验对研究变量进行分析。
本研究共纳入 35 名患者(19 名女性,16 名男性)。所有参与者的平均年龄为 22.19±4.98 岁。8 名患者(对照组 6 例,利福霉素组 2 例)发生牙槽炎。第 2 天和第 7 天,两组在张口受限和肿胀测量方面无统计学差异(p>0.05)。术后第 1 天和第 4 天,利福霉素组的 VAS 评分明显较低(p<0.05)。
在本研究范围内,局部应用利福霉素可降低牙槽炎的发生率,预防感染,并在手术切除下颌阻生第三磨牙后提供镇痛效果。